通过对光合作用细菌衍生的OMVs和挤出的纳米纤维之间进行系统的有益元素比较来定制治疗方法
Tingshan Xiao1,2, Yichuan Ma2,3, Ziyang Zhang1,2
1College of Pharmaceutical Science, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding, 071002, China.
Bioactive materials
|March 4, 2024
概括
光合成细菌衍生的纳米囊 (BNVs) 显示出比外膜囊 (OMVs) 更强大的治疗潜力,原因是活性成分度更高,伤口愈合能力更好. 通过促进细胞增殖和迁移,BNVs加速伤口关闭.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 细胞生物学 细胞生物学
背景情况:
- 光合作用细菌 (PSB) 具有治疗潜力,但面临着尺寸和免疫性等局限性.
- 细菌外膜囊泡 (OMVs) 是一个有希望的替代品,但由于产量低和尺寸不一致而受到影响.
- 细菌衍生的纳米纤维 (BNVs) 通过受控挤出提供了一个解决方案,但它们与OMVs的差异尚不清楚.
研究的目的:
- 调查PSB衍生的OMV和BNV之间的组成和功能差异.
- 评估BNVs和OMVs在伤口愈合和癌症治疗中的治疗潜力.
- 建立选择适合医疗应用的囊泡的标准.
主要方法:
- 来自PSB的OMV和BNV的培养.
- 囊泡形态,大小,组成和活性成分的分析.
- 在NIH-3T3细胞中对BNV和OMV进行体外评估,用于伤口关闭.
- 对OMVs对巨细胞极化和细胞因子释放的影响的评估.
主要成果:
- 与OMV相比,PSB衍生的BNVs表现出最小的形态差异,但活性成分和代谢物度较高.
- BNV含有较高的溶解脂胆 (LPC),促进细胞增殖,血管生成和上皮化.
- 在NIH-3T3细胞中,BNVs通过EGFR/AKT/PI3K通路显著加速伤口关闭.
- OMVs通过促进M1巨分化和炎症性细胞因子释放来证明抗癌潜力.
结论:
- 由于增强的治疗性质,BNVs代表了对OMVs在伤口愈合应用中的优越替代品.
- 通过免疫调节,OMV在抗癌疗法中表现有前途.
- 这项研究提供了一种方法框架和标准,以优化在医学中的BNV和OMV的使用.
相关概念视频
Synthetic Biology
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...


